Aortic Aneurysm Treatment Monitored By Contrast-Enhanced Ultrasound
5/16/2012
Contrast-enhanced ultrasound is an effective, noninvasive method for monitoring patients who undergo endovascular repair for abdominal aortic aneurysms, according to a new study published in the journal Radiology. "Our findings support the addition of contrast-enhanced ultrasound as a complementary tool in the follow-up of these patients," said Rosa Gilabert, M.D., Ph.D...
Revlimid (Lenalidomide) For Myeloma - Phase III Study Findings
5/15/2012
An evaluation of lenalidomide's (Revlimid) long-term 'maintenance' efficacy for patients with multiple myeloma has demonstrated considerable improvements from the time to progression and overall survival for those suffering from this often-fatal form of hematologic cancer. The May 10 issue of the New England Journal of Medicine reports that Dr. Philip L...
Proper Radiotherapy Targeting While The Patient Is Breathing
5/15/2012
Radiotherapists are constantly battling in order to administer the correct dose of radiotherapy, as respiratory movement during radiotherapy poses a certain risk that a tumor receives either a dose that is insufficient, or the surrounding healthy tissue is being subjected to a potentially toxic over-dose. Dr...
Staggered Cancer Drug Delivery Better Than All In One Go
5/15/2012
The fact that treating cancer patients with multiple drugs often results in better outcomes than a single drug treatment is long been known amongst the medical profession. However, a MIT study published in the May 11 issue of Cell has just demonstrated that the order and timing of administering drugs may also have a dramatic impact...
Cervical Cancer Patients Avoid Hysterectomies With Help Of 3-D Imaging Techniques
5/15/2012
A study presented by Dr. Renaud Mazeron at the World Congress of Brachytherapy reveals that many cases of hysterectomy, as well as recurrence and spreading of cancer of the cervix can be controlled effectively by delivering radiotherapy directly to the cancer with 3-D imaging techniques...
HPV Positive Throat Cancer Responds Well To Just Radiotherapy
5/15/2012
New research from Denmark, presented at the 31st Conference of the European Society for Radiotherapy and Oncology (ESTRO31), revealed that even though the human papilloma virus (HPV) can trigger throat cancer, non-smoking or light smoking HPV-positive patients respond well to radiotherapy treatment alone without requiring harmful chemotherapy in addition...
Biomarkers Discovered For Prostate Cancer Detection, Recurrence
5/15/2012
Alterations to the "on-off" switches of genes occur early in the development of prostate cancer and could be used as biomarkers to detect the disease months or even years earlier than current approaches, a Mayo Clinic study has found...
Identification Of A MicroRNA Prognostic Marker In Acute Leukemia
5/15/2012
A study has identified microRNA-3151 as a new independent prognostic marker in certain patients with acute leukemia. The study involves patients with acute myeloid leukemia and normal-looking chromosomes(CN-AML). The study by researchers at the Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J...
Drug Restores Faulty Tumor Suppressor, Kills Cancer
5/15/2012
A new study describes a compound that selectively kills cancer cells by restoring the structure and function of one of the most commonly mutated proteins in human cancer, the "tumor suppressor" p53...
Greater Diversity Than Expected Found In Children's Brain Tumors
5/15/2012
Paediatric brain tumours preserve specific characteristics of the normal cells from which they originate - a previously unknown circumstance with ramifications for how tumour cells respond to treatment. This has been shown by Uppsala researcher Fredrik Swartling together with colleagues in the U.S., Canada and England in a study that was published in the distinguished journal Cancer Cell...